Emotional effects of chemo for gestational trophoblastic neoplasia
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at the emotional and psychological well-being of women after finishing chemotherapy for gestational trophoblastic neoplasia (GTN). It asks women about their feelings and experiences to better understand and support others going through similar treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had chemotherapy for GTN (a rare type of pregnancy-related tumor)
- Finished chemo between 6 weeks and 24 months ago
- Can read and speak English
- Able to understand and agree to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
This trial tests a combination of an immunotherapy drug (toripalimab) and a chemotherapy drug (actinomycin-D) as the first treatment for gestational trophoblastic neoplasia (GTN) with a FIGO score of 5-6. It may help patients whose disease is at a moderate risk level.
This trial tests whether using a hysteroscope (a tiny camera) to gently scrape the uterus again, instead of starting chemotherapy right away, can effectively treat a low-risk, pregnancy-related tumor that returns after a molar pregnancy. It's for Chinese women whose disease is still in an early, low-risk stage.
This trial tests a combination of two drugs — toripalimab (an immunotherapy) and actinomycin-D (chemotherapy) — as the first treatment for a specific type of pregnancy-related tumor (GTN) with a FIGO score of 7. The goal is to see if this combination works better than standard treatment.
This Phase 2 trial studies whether combining camrelizumab (an immune medicine) with apatinib (a medicine that blocks blood-vessel growth) can improve treatment for women with high-risk gestational trophoblastic neoplasia (GTN) that is very high-risk, or has returned or resisted chemotherapy. It may help shrink the tumor and reduce the chance it comes back by using two different approaches together.
This study looks at patients with a high-risk pregnancy-related tumor called gestational trophoblastic neoplasia. It aims to understand their disease features, treatment outcomes, and factors that affect recovery. If you qualify, your medical information may help improve care for others like you.
Hear when a new Gestational Trophoblastic Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.